Celebrating its 5th edition, the B2B Uro-Oncology: GU Cancers Triad meeting returns to the 43rd  Annual Congress in Istanbul, Türkiye, on October 13, 2023, for a full in-person programme, with the latest innovations in uro-oncology. The meeting will also be transmitted live on [email protected], the SIU’s virtual congress platform.

The B2B Uro-Oncology: GU Cancers Triad meeting will feature multidisciplinary, scientific, and educational sessions showcasing cutting-edge content in management of the most prevalent GU malignancies: prostate, bladder, and kidney cancers. Through state-of-the-art presentations, timely debates, and interactive panel discussions, you will:

• Gain insights on the most recent advances in multidisciplinary GU cancer care
• Learn how to apply new strategies and skills to clinical practice for improved patient-centered care
• Engage with world-renowned experts in the uro-oncology community
• Discover cutting-edge research and technologies in the diagnosis and treatment of GU cancers
• Stay current on prospective advances changing the current uro-oncology practice

Stay tuned for additional information and for the programme agenda. In the meantime, revisit key sessions from the 2022 B2B GU Cancers Triad meeting available open access on SIU Academy.